What is the dosage of Sunlenca?

Sunlenca is available in 4 dosages, including mixed Pack, 309 mg/ml Injection 1.5 ml, mixed Pack and mixed Pack

What is Sunlenca mechanism of action?

Sunlenca mechanism of action is P-Glycoprotein Inhibitors, Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 3A Inhibitors or HIV Capsid Inhibitors

Sunlenca Prescribing & Dosing Schedule

Q: How is Sunlenca administered?

Sunlenca is administered as a Pack or Injectable

Dosage & Administration

* Recommended dosage – Initiation with one of two options followed by once every 6-months maintenance dosing. Tablets may be taken without regard to food.

Initiation Option 1
Day 1	927 mg by subcutaneous injection (2 × 1.5 mL injections) 600 mg orally (2 × 300 mg tablets)
Day 2	600 mg orally (2 × 300 mg tablets)
Initiation Option 2
Day 1	600 mg orally (2 × 300 mg tablets)
Day 2	600 mg orally (2 × 300 mg tablets)
Day 8	300 mg orally (1 × 300 mg tablet)
Day 15	927 mg by subcutaneous injection (2 × 1.5 mL injections)
Maintenance
927 mg by subcutaneous injection (2 × 1.5 mL injections) every 6 months (26 weeks) from the date of the last injection +/-2 weeks.

* Missed dose: If more than 28 weeks since last injection and clinically appropriate to continue SUNLENCA, restart initiation from Day 1, using either Option 1 or Option 2.
* Two 1.5 mL subcutaneous injections are required for complete dose.

Get Your Patient on Sunlenca

See your patient's specific prior authorization requirements including coverage restrictions and step therapies

Or select your Insurance from the list below:

Sunlenca Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

Sunlenca Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form

Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form

Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form

Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form

Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form

Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form

Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form

Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form

Verified: Oct 05, 2024Washington - Uniform Prior Authorization Form

Verified: Oct 05, 2024Wisconsin - Uniform Prior Authorization Form

PA Checklist

Benefits investigation

Advancing Access Enrollment Form

Advancing Access Enrollment Form - Online

Sunlenca Preferred Pharmacy

Pharmacy List

Sunlenca Financial Assistance Options

Copay savings program

Advancing Access Enrollment Form

Advancing Access Enrollment Form - Online

Enroll in Patient Savings Program

Activate Co-Pay Card (if already have one)

Replace Co-Pay Card

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

Advancing Access Enrollment Form

Advancing Access Enrollment Form - Online

Patient Assistance Foundation

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

Sunlenca PubMed™ News

Sunlenca Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

About Sunlenca

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Sunlenca FAQs

How is the dosage of Sunlenca?

What does Sunlenca treat?

How Is Sunlenca Administered?

What Are The Sunlenca Mechanism Of Action?

FAQ Data Source